Biomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht and Utrecht University, Utrecht3584 CX, The Netherlands.
Department of Neurology, University of Kentucky, Lexington, Kentucky40506, United States.
ACS Biomater Sci Eng. 2023 Feb 13;9(2):760-772. doi: 10.1021/acsbiomaterials.2c01224. Epub 2023 Jan 22.
Hydrogels have been suggested as novel drug delivery systems for sustained release of therapeutic proteins in various neurological disorders. The main advantage these systems offer is the controlled, prolonged exposure to a therapeutically effective dose of the released drug after a single intracerebral injection. Characterization of controlled release of therapeutics from a hydrogel is generally performed , as current methods do not allow for measurements of spatiotemporal distribution and release kinetics of a loaded protein. Importantly, the environment introduces many additional variables and factors that cannot be effectively simulated under conditions. To address this, in the present contribution, we developed a noninvasive magnetic resonance imaging (MRI) method to monitor local protein release from two injected hydrogels of the same chemical composition but different initial water contents. We designed a biodegradable hydrogel formulation composed of low and high concentration thermosensitive polymer and thiolated hyaluronic acid, which is liquid at room temperature and forms a gel due to a combination of physical and chemical cross-linking upon injection at 37 °C. The protein release kinetics from these gels were assessed by MRI analysis utilizing a model protein labeled with an MR contrast agent, i.e. gadolinium-labeled albumin (74 kDa). As proof of principle, the release kinetics of the hydrogels were first measured with MRI . Subsequently, the protein loaded hydrogels were administered in male Wistar rat brains and the release was monitored for 21 days. , the thermosensitive hydrogels with an initial water content of 81 and 66% released 64 ± 3% and 43 ± 3% of the protein loading, respectively, during the first 6 days at 37 °C. These differences were even more profound , where the thermosensitive hydrogels released 83 ± 16% and 57 ± 15% of the protein load, respectively, 1 week postinjection. Measurement of volume changes of the gels over time showed that the thermosensitive gel with the higher polymer concentration increased more than 4-fold in size after 3 weeks, which was substantially different from the behavior where a volume change of 35% was observed. Our study demonstrates the potential of MRI to noninvasively monitor intracerebral protein release from a locally administered in situ forming hydrogel, which could aid in the development and optimization of such drug delivery systems for brain disorders.
水凝胶已被提议作为治疗性蛋白质在各种神经疾病中缓释的新型药物输送系统。这些系统的主要优势在于,在单次脑内注射后,能够控制并延长释放药物的治疗有效剂量的暴露时间。通常对水凝胶中治疗药物的控制释放进行特征描述,因为目前的方法不允许测量负载蛋白质的时空分布和释放动力学。重要的是,环境会引入许多其他变量和因素,而这些因素在条件下无法有效模拟。为了解决这个问题,在本研究中,我们开发了一种非侵入性磁共振成像(MRI)方法来监测从两种相同化学组成但初始含水量不同的注射水凝胶中局部蛋白质的释放。我们设计了一种可生物降解的水凝胶配方,由低浓度和高浓度热敏聚合物和巯基化透明质酸组成,在室温下为液体,在 37°C 注射时由于物理和化学交联的结合而形成凝胶。通过 MRI 分析利用 MRI 对比剂标记的模型蛋白(即 74 kDa 的钆标记白蛋白)评估这些凝胶的蛋白释放动力学。作为原理验证,首先通过 MRI 测量水凝胶的释放动力学。随后,将负载蛋白的水凝胶施用于雄性 Wistar 大鼠的大脑中,并监测 21 天的释放情况。结果表明,初始含水量分别为 81%和 66%的热敏水凝胶在 37°C 下的最初 6 天内分别释放了 64%±3%和 43%±3%的蛋白载量。这些差异更为明显,热敏水凝胶在注射后 1 周内分别释放了 83%±16%和 57%±15%的蛋白载量。随着时间的推移测量凝胶体积变化表明,聚合物浓度较高的热敏凝胶在 3 周后尺寸增加了 4 倍以上,这与观察到的 35%体积变化的行为有很大不同。我们的研究表明,MRI 具有监测局部给予原位形成水凝胶的脑内蛋白质释放的潜力,这有助于开发和优化此类用于脑疾病的药物输送系统。